Silicon Canals
TRENDING
  • Mobility
  • AI
  • FinTech
  • Software & SaaS
No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdampartner
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team
No Result
View All Result
Silicon Canals
No Result
View All Result

Swedish startup Meds aims to conquer e-pharmacy space post €5M funding

Editorial team by Editorial team
January 14, 2019
in News, Health & Medtech, Startups
0
45
SHARES
LinkedInTwitterWhatsAppFacebook

Stockholm-based e-pharmacy Meds has bagged €5 million in a funding round led by Inbox Capital. The startup has now achieved a total investment of €10.5 million. The funding will be utilised to scale its capacity and market penetration.

Meds delivers medicines in just two hours

Meds sells prescription and non-prescription drugs, cosmetics and health care products on their ecommerce platform. The startup enjoys the approval from the Swedish Medical Products Agency and maintains promptness in delivery.

Founded in 2017, a major proportion of its customer base is from Stockholm itself. The company is briskly upgrading its logistics to cater customers in Malmö and Gothenburg with swift home delivery. Besides sales, Meds offers advice on prescription drugs by a team of licensed pharmacists and maintains a customer support helpline.

Aspires to rule the pharma e-space in Europe

Meds is focusing on developing more warehouses to create an enhanced supply-chain management system. The startup is shedding all its sweat to prevail the Swedish market. Further, it aims to break into the other European markets as well in the coming years.

CEO of Meds, Björn Thorngren stated, “There is a huge interest in everything within e-health right now. The shift in the pharmacy industry is underway. We are going to bring in millions and become the largest of all online pharmacies. This is just one of many rounds. As Sweden is a leader, we will have a lot to offer when other countries follow suit. We want to become a kind of Uber for health in Europe.”

Stay tuned to Silicon Canals for more updates in the tech startup world.

Did you know you can post your job for free on our job board? If you require extra promotion, reach out to [email protected] for a discounted offer

close

Want to stay on top of the latest rounds, coolest tech and hottest startups?

Subscribe to our free, daily news blast and stay up-to-date!

Check your inbox or spam folder to confirm your subscription.

 - Partner content -
Future Hamburg Award 2021
Future Hamburg Award 2021
Call for startups with innovative solutions for the future cities from all over the globe.
Call for startups with innovative solutions for the future cities from all over the globe. Show Less
Read more
Tags: fundinghealthstartup
Share3Tweet11SendShare18

Featured events

Current Month

april

14apr11:0012:00FeaturedFree Webinar: GRECA – investor search via digital matching

Partner content | Work with us

Calling all European deep-tech scaleups: EIT Digital Challenge 2021 registration is now open

Amsterdam-based SaaS startup SwipeGuide raises €5M for international expansion; aims to double its staff in 2021

Innovation against climate change: what Blue Tulip Awards’ experts on Climate & Energy are looking for

Blue Tulip Awards’ experts of Finance & Prosperity: why COVID, regulations and digitisation boost innovation

Former Booking.com CEO Kees Koolen backs €5.2M funding round of Amsterdam’s cleantech startup Sympower

Silicon Canals Jobs


Breaking news from Amsterdam | Partner

Amsterdam’s IoT spacetech startup Hiber raises €26M to expand the world’s first global IoT satellite network

Amsterdam-based MessageBird acquires 24sessions to add video to its omnichannel offering; also acquires Hull

Techstars ties up with ABN AMRO to launch ‘Future of Finance Accelerator’; welcomes 10 startups to Amsterdam

Amsterdam-based fintech Recharge.com raises €10M in debt funding; appoints Azimo’s Michael Kent as new chairman

  • About Silicon Canals
  • Partner with Silicon Canals
  • Contact us
  • Newsletter
  • Disclaimer
  • Privacy policy
  • Terms & Conditions Silicon Canals

Silicon Canals 2014-2020 | Website: Bright Idiots

No Result
View All Result
  • Home
  • News
    • COVID-19
    • Startups
    • Scaleups
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Features
    • Promoted content
    • How-to
    • Knowledge & Insights
    • Guest Contributions
    • Scaling-up in Europe
  • Amsterdam
  • Events
  • Jobs
  • Partner with us
  • About us
    • About
    • Contact
    • Newsletter
    • Team

Silicon Canals 2014-2020 | Website: Bright Idiots

X

This website uses cookies to ensure the best possible experience. We may share this information with our advertising and analytics partners. By clicking 'Accept', you agree to our use of cookies and similar technologies. More info